Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / LABP - Landos Biopharma announces key transitions

LABP - Landos Biopharma announces key transitions

Landos Biopharma Inc.
A clinical-stage biopharmaceutical company, Landos Biopharma (NASDAQ:LABP) announces that Josep Bassaganya-Riera, Ph.D., has stepped down as Chairman, President and CEO, effective immediately. Tim M. Mayleben, a member of the Board, has been appointed Interim President and CEO. Chris Garabedian, also a Director, has been appointed Chairman of the Board. Dr. Bassaganya-Riera will serve as an advisor to the company to ensure a smooth transition. The Board will initiate a search process to identify its next CEO. Mr. Garabedian continued, “The Board of Directors has appointed Tim Mayleben as Interim CEO to lead the Company during this transition period as we focus on building a highly-experienced leadership team through this important next phase of development. Tim brings more than two decades of leadership experience in the development and approval of innovative therapies. Since joining our Board, he has played an invaluable role in helping Landos navigate the market as a publicly traded company while advancing strategies

For further details see:

Landos Biopharma announces key transitions
Stock Information
Company Name: Landos Biopharma Inc.
Stock Symbol: LABP
Market: NASDAQ
Website: landosbiopharma.com
Menu
LABP LABP Quote LABP Short LABP News LABP Articles LABP Message Board
Get LABP Alerts

News, Short Squeeze, Breakout and More Instantly...